company background image
VB0 logo

Viva Biotech Holdings DB:VB0 Stock Report

Last Price

€0.059

Market Cap

€133.9m

7D

0.9%

1Y

-66.2%

Updated

25 Mar, 2024

Data

Company Financials

VB0 Stock Overview

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

VB0 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Viva Biotech Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Viva Biotech Holdings
Historical stock prices
Current Share PriceHK$0.059
52 Week HighHK$0.21
52 Week LowHK$0.052
Beta1.09
1 Month Change-5.65%
3 Month Change-44.81%
1 Year Change-66.19%
3 Year Change-92.09%
5 Year Changen/a
Change since IPO-88.60%

Recent News & Updates

Recent updates

Shareholder Returns

VB0DE Life SciencesDE Market
7D0.9%4.1%1.6%
1Y-66.2%-5.0%6.4%

Return vs Industry: VB0 underperformed the German Life Sciences industry which returned -3.7% over the past year.

Return vs Market: VB0 underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is VB0's price volatile compared to industry and market?
VB0 volatility
VB0 Average Weekly Movement12.8%
Life Sciences Industry Average Movement6.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: VB0's share price has been volatile over the past 3 months.

Volatility Over Time: VB0's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20082,271Chen Cheney Maohttps://www.vivabiotech.com.cn

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure analysis of protein, and SPR technology; and PROTAC/molecular glue services. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins.

Viva Biotech Holdings Fundamentals Summary

How do Viva Biotech Holdings's earnings and revenue compare to its market cap?
VB0 fundamental statistics
Market cap€133.89m
Earnings (TTM)-€55.82m
Revenue (TTM)€308.77m

0.4x

P/S Ratio

-2.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VB0 income statement (TTM)
RevenueCN¥2.41b
Cost of RevenueCN¥1.54b
Gross ProfitCN¥876.68m
Other ExpensesCN¥1.31b
Earnings-CN¥436.26m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)-0.20
Gross Margin36.33%
Net Profit Margin-18.08%
Debt/Equity Ratio78.9%

How did VB0 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.